Patients
  Healthcare Professionals
  Business Development
  Investors
Home About Us Investors Products Pipeline News and Reports Contact Us
Business Model
History
Management
Regulatory
Sinclair Sales and Marketing
France
UK
Italy
Spain
Portugal
Business Development
Business Development Contacts
Become a Sinclair Partner
Corporate Policies
 
 
 
   

Sinclair Pharma was re-registered as a public limited company on 28 November 2003.

In December 2003, Sinclair was listed on the London Stock Exchange's Alternative Investment Market ("AIM) - SPHL - raising a total of £21.8 million, £8.9million of new capital (net of expenses). The company name changed accordingly to Sinclair Pharma plc.

Further details can be found at our Investor Relations site.

   
France Japan Spain Italy Germany
Search
page select  
search  

 
 
Fadiamone
Fadiamone - for anti-ageing
 
Privacy Policy Site Map